Jason Meyenburg: CEO of Gemini Therapeutics

Portrait of Jason Meyenburg

Gemini Therapeutics CEO Jason Meyenburg share his thoughts about leadership in biopharma with BioBoss host John Simboli.  Jason also discusses Gemini Therapeutics pioneering approach to developing precision medicines by leveraging genetics to work in diseases like dry AMD and linked diseases that have limited or no solutions.

Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom

Computer chip/molecular design concept animation.
TandemAI

Discovery as a Service

1% Steps for Health Care Reform Policy Brief Authors Portraits
1% Steps for Health Care Reform

Shifting How We Think About Health Care Spending